Article Information
History
- September 14, 2018.
Article Versions
- You are currently viewing Version 1 of this article (September 14, 2018 - 14:46).
- Version 2 (October 30, 2018 - 22:04).
- Version 3 (May 2, 2019 - 20:38).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hemalatha Babu1,2,
- Anoop T Ambikan2,
- Erin E Gabriel3,
- Sara Svensson Akusaravi2,
- Naveen Reddy Mupanni2,
- Maike Sperk2,
- Narayanaiah Cheedarla1,
- Alangudi Natarajan Palaniapan6,
- Rathinam Sridhar4,
- Vijila Sundaraj4,
- Srikanth P Tripathy1,
- Piotr Nowak5,
- Luke Elizabeth Hanna1,* and
- Ujjwal Neogi2,*
- 1Department of HIV/AIDS, National Institute for Research in Tuberculosis, ICMR, Chennai, India
- 2Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
- 3Department of Medical Epidemiology and Biostatistics and Institute of Environmental Medicine both of Karolinska Institutet Stockholm, Sweden
- 4Government Hospital of Thoracic Medicine, Tambaram Sanatorium, Chennai, India
- 5Department of Medicine Huddinge, Unit of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- 6Department of Clinic, National Institute for Research in Tuberculosis, ICMR, Chennai, India.
- ↵*Correspondence:
Ujjwal Neogi, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden, e-mail- ujjwal.neogi{at}ki.se, Phone: +46 852483680 Luke Elizabeth Hanna, Department of HIV/AIDS, National Institute for Research in Tuberculosis, ICMR, Chennai, India, e-mail- hannatrc{at}yahoo.com